Moreover, using immunohistochemistry and immunofluorescence, we demonstrated the presence of SGLT1 and SGLT2 in the human peritoneum in biopsies from healthy non-CKD control and PD patients, respectively (Figure 1B). Here, SLC5A2 is linked to chronic kidney disease.